Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans

Vascular Health and Risk Management

Volumn 8, Issue 1, 2012, Pages 455-461

  Longo Mbenza, Benjamin ^a   Nsenga, Jacqueline Nkondi ^b   Mokondjimobe, Etienne ^c   Gombet, Thierry ^c   Assori, Itoua Ngaporo ^c   Ibara, Jean Rosaire ^c   Ellenga Mbolla, Bertrand ^c   Vangu, Dieudonné Ngoma ^d   Fuele, Simon Mbungu ^d  

^a WALTER SISULU UNIVERSITY   (South Africa)

^b UNIVERSITY OF KINSHASA   (Congo)

^c University of Marien Ngouabi   (Democratic Republic Congo)

^d Lomo Medical Center   (Democratic Republic Congo)

Author keywords

Africans; Cardiovascular disease; Carotid plaque; Helicobacter pylori; Myocardial infarction; Stroke

Indexed keywords

FIBRINOGEN; GLUCOSE; IMMUNOGLOBULIN G ANTIBODY; BACTERIUM ANTIBODY; BIOLOGICAL MARKER; LIPID; URIC ACID;

ADULT; ANGINA PECTORIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CENTRAL AFRICA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RISK; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; DEMOCRATIC REPUBLIC CONGO; ETHNOLOGY; FOLLOW UP; HELICOBACTER PYLORI; HEMODYNAMICS; IMMUNOLOGY; INCIDENCE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MULTIVARIATE ANALYSIS; NEGRO; PATHOPHYSIOLOGY; RISK; RISK FACTOR; STATISTICAL MODEL; STATISTICS; TIME; WAIST CIRCUMFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEMODYNAMICS; HUMANS; INCIDENCE; LIPIDS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; URIC ACID; WAIST CIRCUMFERENCE;

EID: 84872235159     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S28680     Document Type: Article

References (36)

1. World Health Organization. Preventing Chronic Diseases: A vital investment. Geneva, Switzerland: WHO; 2005.
2. World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: WHO; 2002.
3. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-1757.
4. Steyn K, Sliwa K, Hawken S, et al. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005;112:3554-3561.
5. Yusu S, Hawken S, Ounpuu S, et al; for INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-952.
6. Walker AR, Sareli P. Coronary heart disease: outlook for Africa. J R Soc Med. 1997;90:23-27.
7. Longo-Mbenza B, Luila EL, Mbete P, Vita EK. Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans? Int J Cardiol. 1999;71(1):17-22.
8. Longo-Mbenza B, Tonduangu K, Muyeno K, et al. Predictors of stroke-associated mortality in Africans. Rev Epidemiol Sante Publique. 2000;48(1):31-39.
9. Rajasekhar D, Subramanyam G, Latheef SA, Vanajakshamma V, Srilatha A, Chaudhury A. Infectious aetiology in acute coronary syndromes. Indian J Med Microbiol. 2002;20(2):83-87.
10. Khodaii Z, Vakili H, Ghaderian SM, Najar RA, Panah AS. Association of Helicobacter pylori infection with acute myocardial infarction. Coron Artery Dis. 2011;22(1):6-11.
11. Akbas HS, Basyigit S, Suleymanlar I, Kemaloglu D, et al. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects. Lipids Health Dis. 2010;9:92.
12. Satoh H, Saijo Y, Yoshioka E, Tsutsui H. Helicobacter pylori infection is a significant risk for modified lipid profile in Japanese male subjects. J Atheroscler Thromb. 2010;17(10):1041-1048.
13. Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerosis diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol. 2007;121:229-238.
14. Longo-Mbenza B, Mambune HF, Kasiam JB, et al. Relationship between waist circumference and cholesterol in Central Africans with congestive heart failure. West Afr J Med. 2007;26:183-190.
15. Christodoulou DK, Milionis HJ, Pappa P, et al. Association of Helicobacter pylori infection with cardiovascular disease - is it just a myth? Eur J Intern Med. 2011;22:191-194.
16. Suzuki H, Nishizawa T, Hibi T. Helicobacter pylori eradication therapy. Future Virol. 2010;5:639-648.
17. Pellicano R, Oliaro E, Fagoonee S, et al. Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication. Int Angiol. 2009;28:469-473.
18. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Bristol, UK: John Wright; 1982.
19. World Health Organization. Measuring Obesity: Classification and description of anthropometric data. Copenhagen, Denmark: WHO; 1989.
20. Guidelines Subcommittee, 1999 WHO. International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151-183.
21. Tang R, Hennig M, Thomasson B, et al. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens. 2000;18:197-201.
22. Bond MG, Wilmoth SK, Enevold GL, Strickland HL. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. Am J Med. 1989;86:33-36.
23. Molarius A, Seidell JC, Sana S, Tuomilehto J, Kuulasmaa K. Varying sensitivity of waist action levels to identify subjects with overweight or obesity in 19 populations of the WHO MONICA project. J Clin Epidemiol. 1999;52:1213-1224.
24. Zanchette A, Bond MG, Hennig M, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 1998;16:949-961.
25. University of Bristol Information Services. Introduction to SPSS (version 18) for Windows. Practical workbook. Available from: http://www.bristol.ac.uk/it-services/learning/documentation/spss18-2/spss18-2t.pdf. Accessed December 12, 2011.
26. World Health Organization Regional Office for Africa. Noncommunicable Diseases: A Strategy for the African region. Harare, Zimbabwe: WHO; 2000.
27. Akinboboye O, Idris O, Akinboboye O, Akinkugbe O. Trends in coronary artery disease and associated risk factors in sub-Saharan Africans. J Hum Hypertens. 2003;17:381-387.
28. Khairy P, Rinfret S, Tardif JC, et al. Absence of association between infectious agents and endothelial function in healthy young men. Circulation. 2003;107:1966-1971.
29. Park MJ, Choi SH, Kim D, et al. Association between Helicobacter pylori seropositivity and the coronary artery calcium score in a screening population. Gut Liver. 2011;5(3):321-327.
30. Corrado E, Rizzo M, Tantillo R, et al. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke. 2006;37:482-486.
31. Mayr M, Kiechl S, Tsimikas S, et al. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study. J Am Coll Cardiol. 2006;47(12):2436-2443.
32. Spence JD, Norris J. Infection, inflammation, and atherosclerosis. Stroke. 2003;34:333-334.
33. Marra M, Bonfigli AR, Bonazzi P, et al. Asymptomatic Helicobacter pylori infection increases asymmetric dimethylarginine levels in healthy subjects. Helicobacter. 2005;10(6):609-614.
34. Elkind MS, Luna JM, Moon YP, et al. Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke. 2010;41(3): e117-e122.
35. Suzuki H, Matsuzaki J, Hibi T. Lifestyle-related diseases and H. pylori. Nihon Rinsho. 2009;67(12):2366-2371.
36. Nazmi A, Diez-Roux AV, Jenny NS, Tsai MY, Szklo M, Aiello AE. The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis. BMC Public Health. 2010;10:706.